Boehringer Ingelheim Australia (BIAU) respects individual privacy and the rights of individuals to control their personal information. BIAU supports and follows the 10 National Privacy Principles. Our employees are trained in the importance of an individual's privacy. Boehringer Ingelheim Australia strives to ensure that all personal and sensitive information that we collect, hold and use is accurate, complete and up to date.
Information Collected from this Website
Boehringer Ingelheim Australia will only collect personal and sensitive information by lawful, fair and non-intrusive means. We will only collect sensitive information with the individual's consent.
This website may collect information through information provided in the "Contact Us" Form. This information will only be used for the purpose of responding to your comment or query.
This website may also collect information that does not reveal your identity such as time and date of your website visit or the pages your accessed. This type of collective information will allow Boehringer Ingelheim to measure what areas of the website are visited the most frequently. This information will also help us to determine what is most beneficial for our users and allow us to continually create a better service for you. This information is not used to identify individual users.
Cookies
This website may use a cookie. Cookies are small text files placed on your hard drive to store information. Your internet browser can be set to reject cookies or to notify you when they are being used. You can disable cookies by turning them off in your browser. This website may not function correctly if you do so.
- Boehringer Ingelheim Australia will not collect personal information with regard to an individual's:
- Political opinions or membership of a political association;
- Trade union membership;
- Sexual preferences;
- Criminal record.
Use of Sensitive Information
Boehringer Ingelheim Australia may collect health information as a result of customer complaints, enquiries or an adverse reaction to a product. This information is held in a secure database or in hardcopy in a secure office.
Disclosure of Sensitive Information
Sensitive Information collected by Boehringer Ingelheim Australia from the reporting of an adverse drug reaction is disclosed to the Australian Pesticides and Veterinary Medicines Authority (APVMA). It is a condition of registration of drugs in Australia that all adverse events are reported to the APVMA. Information collected from adverse events and customer complaints is sent to Boehringer Ingelheim offices overseas for the purpose of ensuring product safety, efficacy and quality. This information is only disclosed with the individual's consent.
- Individuals may access their personal information held by BIAU by completing a Request for Access to Information Form. This form can be obtained from the Privacy Officer. BIAU will not charge a fee for the lodgement of a Request, however fees may be incurred for the provision of information. Fees charged for access to personal information will be based on:
- the staff costs involved in locating and collating information;
- reproduction costs,
- costs incurred when bringing files back from archive
- the cost of staff time in preparing and explaining the information provided.
Fee details are provided on the Request for Access to Information Form.
Refusing Access to Personal Information- BIAU may refuse an individual's access to their personal information under the following circumstances:
- in the case of personal information other than health information, if providing access would pose a serious and imminent threat to the life or health of any individual;
- in the case of health information, if providing access would pose a serious threat to the life or health of any individual;
- if providing access would have an unreasonable impact upon the privacy of other individuals;
- if the request for access is frivolous or vexatious;
- if the information relates to existing or anticipated legal proceedings between the individual and BIAU and the information would not be accessible by the process of discovery;
- if providing access would reveal the intentions of BIAU in relation to negotiations with the individual in such a way as to prejudice those negotiations;
- if providing access would reveal evaluative information generated within BIAU in connection with a commercially sensitive decision-making process;
- as otherwise allowed by the Privacy Amendment Act 2000.
Correcting Personal Information
BIAU will take reasonable steps to correct information about an individual where that information is not accurate, up-to-date or correct. Individuals wishing to have information corrected should complete a Request for Correction to Personal Records Form. This form can be obtained from the Privacy Officer. No charges will be incurred for the correction of records.
It is the responsibility of the individual seeking the correction to demonstrate that the information held by BIAU is not accurate, up-to-date or complete. Information will not be changed where this cannot be demonstrated. Instead BIAU will attach a notice to the individual's personal information outlining the nature of the individual's claim that the information was incorrect, out of date or incomplete.
Further Information
For further information on BIAU's information handling and privacy practices please contact the Privacy Officer.
All requests for access to personal information require a Request for Access to Information Form to be completed. Forms can be obtained from the Privacy Officer.
All complaints or claims of privacy breaches should be submitted to the Privacy Officer in writing.
For further information please contact:
Patricia Miranda-Brucker
Privacy Officer
Boehringer Ingelheim
PO Box 1969 Macquarie Centre
North Ryde 2113
Patricia.MirandaBrucker@boehringer-ingelheim.com
02 8875 8800
